DONATE

Norman Todd is hoping to play a role in helping future patients discover his same quality of life by taking part in a Foundation-funded clinical trial. “I appreciate all that the people who went before me did to help develop new treatments, and I want to do what I can to help someone else in the future.” Continue Reading

Norman Todd

When you consider all the things you’d like to pass on to your children, cancer certainly doesn’t make the list. But given her family’s history, Ann Best knew it was a possibility. After much deliberation, Ann underwent genetic testing and many family members followed. Knowing the important role the Foundation plays in helping promote and advance testing locally; Ann remains a vocal advocate, serving as a volunteer, donor and board member. “For my kids, I want to see really good research continue right here. The Foundation helps keep Illinois CancerCare on the cutting edge of treatments and therapies.” Continue Reading

Ann Best

Millard Diseker

Millard Diseker
May 8, 2017
    

Asked which is tougher, war or cancer, U.S. Navy veteran Millard Diseker doesn’t hesitate. “Cancer is bad, but war is worse. This is a different kind of fight.”

It’s a battle he’s been waging for some time now. Diagnosed with prostate and colon cancer eight years ago, Millard underwent treatment and spent seven years cancer-free. But the disease returned, and now he’s in the midst of a two-year chemotherapy program. Despite side effects like fatigue, insomnia, mood swings and hot flashes, Millard remains positive about his treatment— a new drug combination that’s part of a Foundation-funded clinical trial aimingto increase prostate cancer survival rates—and his future.

Cancer took Millard’s first wife, Paula, three years ago, but he’s been fortunate to find love again with his fiancée, Carol, and the two hope to get married in the spring. He credits the team at Illinois CancerCare for standing shoulder to shoulder with him throughout his fight. “They’re fabulous people. From the lab, to the pharmacy, to the treatment pod, everyone here is so kind-hearted. They always have your six.”

Since 1979, nearly 10,000 cancer patients have participated in more than 1,400 clinical trials through Illinois CancerCare, many funded in part by your contributions to the Foundation. Unlike bench research, which is conducted in a lab with test tubes and animals, clinical trials are applied research using human subjects—essential in advancing cutting-edge care and offered comfortably close to home.